A citation-based method for searching scientific literature

Chris H Polman, Stephen C Reingold, Gilles Edan, Massimo Filippi, Hans-Peter Hartung, Ludwig Kappos, Fred D Lublin, Luanne M Metz, Henry F McFarland, Paul W O'Connor, Magnhild Sandberg-Wollheim, Alan J Thompson, Brian G Weinshenker, Jerry S Wolinsky. Ann Neurol 2005
Times Cited: 3740







List of co-cited articles
484 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos,[...]. Ann Neurol 2011
60

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
W I McDonald, A Compston, G Edan, D Goodkin, H P Hartung, F D Lublin, H F McFarland, D W Paty, C H Polman, S C Reingold,[...]. Ann Neurol 2001
37

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
34


New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
C M Poser, D W Paty, L Scheinberg, W I McDonald, F A Davis, G C Ebers, K P Johnson, W A Sibley, D H Silberberg, W W Tourtellotte. Ann Neurol 1983
24

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.
G A SCHUMACHER, G BEEBE, R F KIBLER, L T KURLAND, J F KURTZKE, F MCDOWELL, B NAGLER, W A SIBLEY, W W TOURTELLOTTE, T L WILLMON. Ann N Y Acad Sci 1965
12

Defining the clinical course of multiple sclerosis: the 2013 revisions.
Fred D Lublin, Stephen C Reingold, Jeffrey A Cohen, Gary R Cutter, Per Soelberg Sørensen, Alan J Thompson, Jerry S Wolinsky, Laura J Balcer, Brenda Banwell, Frederik Barkhof,[...]. Neurology 2014
12


Multiple Sclerosis.
Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
686
8

Defining secondary progressive multiple sclerosis.
Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette,[...]. Brain 2016
142
8



Evidence for a two-stage disability progression in multiple sclerosis.
Emmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page, Marc Coustans, David Laplaud, Joël Oger, Gilles Edan. Brain 2010
342
6

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.
S M Rao, G J Leo, L Bernardin, F Unverzagt. Neurology 1991
6

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
H Butzkueven, J Chapman, E Cristiano, F Grand'Maison, M Hoffmann, G Izquierdo, D Jolley, L Kappos, T Leist, D Pöhlau,[...]. Mult Scler 2006
111
6

Importance of early treatment initiation in the clinical course of multiple sclerosis.
Andrius Kavaliunas, Ali Manouchehrinia, Leszek Stawiarz, Ryan Ramanujam, Jonas Agholme, Anna Karin Hedström, Omid Beiki, Anna Glaser, Jan Hillert. Mult Scler 2017
67
8

Silent progression in disease activity-free relapsing multiple sclerosis.
Bruce A C Cree, Jill A Hollenbach, Riley Bove, Gina Kirkish, Simone Sacco, Eduardo Caverzasi, Antje Bischof, Tristan Gundel, Alyssa H Zhu, Nico Papinutto,[...]. Ann Neurol 2019
99
6

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.
Massimo Filippi, Maria A Rocca, Olga Ciccarelli, Nicola De Stefano, Nikos Evangelou, Ludwig Kappos, Alex Rovira, Jaume Sastre-Garriga, Mar Tintorè, Jette L Frederiksen,[...]. Lancet Neurol 2016
373
6

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
Tomas Olsson, Lisa F Barcellos, Lars Alfredsson. Nat Rev Neurol 2017
339
6

Multiple sclerosis.
Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A Rocca. Nat Rev Dis Primers 2018
262
6

Multiple sclerosis.
Alan J Thompson, Sergio E Baranzini, Jeroen Geurts, Bernhard Hemmer, Olga Ciccarelli. Lancet 2018
525
6

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Stephen Sawcer, Garrett Hellenthal, Matti Pirinen, Chris C A Spencer, Nikolaos A Patsopoulos, Loukas Moutsianas, Alexander Dilthey, Zhan Su, Colin Freeman, Sarah E Hunt,[...]. Nature 2011
6

Multiple sclerosis.
Alastair Compston, Alasdair Coles. Lancet 2002
5

Multiple sclerosis.
Alastair Compston, Alasdair Coles. Lancet 2008
5

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
B G Weinshenker, B Bass, G P Rice, J Noseworthy, W Carriere, J Baskerville, G C Ebers. Brain 1989
5

Long-term evolution of multiple sclerosis disability in the treatment era.
Bruce A C Cree, Pierre-Antoine Gourraud, Jorge R Oksenberg, Carolyn Bevan, Elizabeth Crabtree-Hartman, Jeffrey M Gelfand, Douglas S Goodin, Jennifer Graves, Ari J Green, Ellen Mowry,[...]. Ann Neurol 2016
188
5

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Wallace J Brownlee, Dan R Altmann, Ferran Prados, Katherine A Miszkiel, Arman Eshaghi, Claudia A M Gandini Wheeler-Kingshott, Frederik Barkhof, Olga Ciccarelli. Brain 2019
49
10

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Mar Tintore, Àlex Rovira, Jordi Río, Susana Otero-Romero, Georgina Arrambide, Carmen Tur, Manuel Comabella, Carlos Nos, María Jesús Arévalo, Laura Negrotto,[...]. Brain 2015
259
5

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi,[...]. JAMA 2019
136
5

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Peter Chang, Anthony Hamlett, Bruno Musch,[...]. N Engl J Med 2010
465
5

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
725
5



Cognitive impairment in multiple sclerosis.
Nancy D Chiaravalloti, John DeLuca. Lancet Neurol 2008
5

The changing demographic pattern of multiple sclerosis epidemiology.
Nils Koch-Henriksen, Per Soelberg Sørensen. Lancet Neurol 2010
639
5

Age and disability accumulation in multiple sclerosis.
A Scalfari, A Neuhaus, M Daumer, G C Ebers, P A Muraro. Neurology 2011
149
4

MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
Francois Cotton, Howard L Weiner, Ferenc A Jolesz, Charles R G Guttmann. Neurology 2003
150
4

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
Claudio Gasperini, Luca Prosperini, Mar Tintoré, Maria Pia Sormani, Massimo Filippi, Jordi Rio, Jacqueline Palace, Maria A Rocca, Olga Ciccarelli, Frederik Barkhof,[...]. Neurology 2019
41
9

Relapses and progression of disability in multiple sclerosis.
C Confavreux, S Vukusic, T Moreau, P Adeleine. N Engl J Med 2000
836
4

Clinically isolated syndromes.
David H Miller, Declan T Chard, Olga Ciccarelli. Lancet Neurol 2012
249
4

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.
Pascal Sati, Jiwon Oh, R Todd Constable, Nikos Evangelou, Charles R G Guttmann, Roland G Henry, Eric C Klawiter, Caterina Mainero, Luca Massacesi, Henry McFarland,[...]. Nat Rev Neurol 2016
134
4

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
F Barkhof, M Filippi, D H Miller, P Scheltens, A Campi, C H Polman, G Comi, H J Adèr, N Losseff, J Valk. Brain 1997
919
4


Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
A Traboulsee, J H Simon, L Stone, E Fisher, D E Jones, A Malhotra, S D Newsome, J Oh, D S Reich, N Richert,[...]. AJNR Am J Neuroradiol 2016
179
4

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Robert J Fox, David H Miller, J Theodore Phillips, Michael Hutchinson, Eva Havrdova, Mariko Kita, Minhua Yang, Kartik Raghupathi, Mark Novas, Marianne T Sweetser,[...]. N Engl J Med 2012
848
4


Brain health: time matters in multiple sclerosis.
Gavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, Jeremy Hobart, Gisela Kobelt, George Pepper, Maria Pia Sormani, Christoph Thalheim, Anthony Traboulsee, Timothy Vollmer. Mult Scler Relat Disord 2016
150
4

The clinical course of multiple sclerosis.
Christian Confavreux, Sandra Vukusic. Handb Clin Neurol 2014
84
4


Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Aaron E Miller, Jerry S Wolinsky, Ludwig Kappos, Giancarlo Comi, Mark S Freedman, Tomas P Olsson, Deborah Bauer, Myriam Benamor, Philippe Truffinet, Paul W O'Connor. Lancet Neurol 2014
175
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.